Jeffrey Rado, MD
Psychiatry · Chicago, ILNPI 1881706455
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $135,272 of the $207,922 with a category attached, or 65.1%. 12 manufacturers reported payments, led by Alkermes, Inc. at 59.0% of the total. 2025 is the largest year on record at $64,211, 2.2 times the $29,169 reported in 2019. Among psychiatry clinicians in IL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 230 payments — averaging $904.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alkermes, Inc.$123K
- E.r. Squibb & Sons, L.L.C.$34K
- Axsome Therapeutics, Inc.$20K
- Boehringer Ingelheim International GmbH$9K
- Janssen Global Services, LLC$8K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$5K
- plus $10K from 6 others
Across 313 payments — averaging $3231.61 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Hoffmann-la Roche Limited$226K
- Alkermes, Inc.$210K
- Acadia Pharmaceuticals Inc$146K
- Biogen$125K
- E.r. Squibb & Sons, L.L.C.$103K
- Janssen Research & Development, LLC$68K
- plus $133K from 5 others
What the payments were for
- Consulting fees$57,26028%
- Speaking & faculty fees$135,27265%
- Travel & lodging$8,9084%
- Food & beverage$6,4823%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alkermes, Inc. | 135 | $122,669 |
| E.r. Squibb & Sons, L.L.C. | 33 | $34,154 |
| Axsome Therapeutics, Inc. | 26 | $19,942 |
| Boehringer Ingelheim International GmbH | 7 | $8,800 |
| Janssen Global Services, LLC | 9 | $7,903 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 5 | $4,542 |
| H. Lundbeck A S | 5 | $3,844 |
| Noven Pharmaceuticals, Inc. | 3 | $2,390 |
| Indivior Inc. | 1 | $1,788 |
| Janssen Scientific Affairs, LLC | 1 | $1,450 |
| Boehringer Ingelheim | 4 | $320 |
| Sage Therapeutics, LLC | 1 | $120 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LYBALVI$303,064
- ARISTADA$159,882
- ARISTADA INITIO$39,750
- Auvelity$19,519
- COBENFY$11,314
- SPRAVATO$5,526
- CAPLYTA$4,500
- ABILIFY MAINTENA$3,765
- SECUADO$2,390
- PERSERIS$1,788
How this compares
$207,922 in reported general payments places this provider in the 95th percentile of 1,344 psychiatry providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 17 | $58,735 |
| Clozapine | 76 | $10,707 |
| Divalproex Sodium ErDivalproex Sodium | 36 | $6,653 |
| BelsomraSuvorexant | 13 | $6,584 |
| Quetiapine Fumarate | 117 | $1,849 |
| Olanzapine | 70 | $1,762 |
| Aripiprazole | 47 | $1,628 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 36 | $1,613 |
| Bupropion XlBupropion Hcl | 74 | $1,613 |
| Duloxetine Hcl | 72 | $1,561 |
| Ziprasidone Hcl | 12 | $1,080 |
| Fluoxetine Hcl | 61 | $933 |
| Gabapentin | 45 | $827 |
| Lamotrigine | 75 | $789 |
| Trazodone Hcl | 57 | $575 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Chicago
- Mitchell GlaserChicago$752K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- K Ranga KrishnanChicago$92K
- Richard BaerChicago$44K
- Adam GoldenbergChicago$23K
- Olusola AjiloreChicago$21K
- Emil CoccaroChicago$20K
- Guarava AgarwalChicago$20K
- Jon GrantChicago$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.